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Graphical Abstract 
 
 
 
Highlights  
 E50LV, E4M and E10M HPMC polymers are effective in dissipating electrostatic 
charge of the API (theophylline)  
 Triboelectrification enabled optimum charge to mass ratio to be measured.  
 Systematic agitation has effect on drug release from E50LV and E4M  
 Stiffness of gel increases with increasing molecular weight 
 E10M tablet matrices most resilient of matrices tested 
 
Abstract 
The aim of the study was to evaluate the effect of systematic agitation, increasing ionic 
strength and gel strength on drug release from a gel-forming matrix (HPMC E10M, E4M and 
E50LV) using USP type III Bio-Dis apparatus with theophylline as a model drug. The 
triboelectric charging; particle sizing, water content, true density and SEM of all the 
hypromellose grades, theophylline and formulated blends were characterised.  The results 
showed that balanced inter-particulate forces exist between drug particles and the excipient 
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surface and this enabled optimum charge to mass ratio to be measured. Agitation and ionic 
strength affected drug release from E50LV and E4M tablet matrices in comparison to the 
E10M tablet matrices. Drug release increased substantially when water was used as the 
dissolution media relative to media at pH 1.2 (containing 0.4 M NaCl). The results showed all 
f2 values for the E10M tablet matrices were above 50 suggesting the drug release from these 
tablet matrices to be similar. Rheological data also explained the different drug release 
behaviour with the stress required to yield/erode being 1 Pa, 150 Pa, and 320 Pa, for the 
E50LV, E4M and E10M respectively. The stiffness of the gel was also found to be varied 
from 2.5 Pa, 176.2 Pa and 408.3 Pa for the E50 LV, E4M and E10M respectively. The lower 
G’ value can be explained by a softer gel being formed after tablet introduction into the 
dissolution media thereby indicating faster drug release.  
Keywords: Agitation sequence; ionic concentration strength; HPMC polymeric matrix tablets 
triboelectrification, USP III apparatus, rheology 
1. Introduction 
Polymer based matrix systems are popular in controlled release formulations in terms of 
economic, process development and scale up procedures [1-5].  Polymer-based matrix tablets 
swell once in contact with fluid, forming a gel-layer, which controls drug release from the 
formulation. The release of drug from the swollen gel matrix depends on the possible 
interactions between the aqueous dissolution medium, polymer, drug and other tablet 
ingredients [6-8]. An important factor that affects bioavailability of drugs is the presence of 
food due to potential interactions that may occur between the formulation and the food [9, 10] 
such as chelation of penicillamine by iron in the gut leading to reduction in its absorption and 
activity. Furthermore, the physiological response to ingestion of food such as gastric acid 
secretion may increase of decrease the bioavailability of some drugs [11-13]. pH and ionic 
strength of the gastrointestinal (GI) fluids  vary greatly along the GI tract under both fasted  
and fed conditions [14, 15] and this can affect the rate at which a drug is released from 
hydrophilic extended release (ER) matrices [16-20]. The gel layer formed around hydrophilic 
matrices, upon its contact with GI fluids, is eroded allowing drug release. Erosion is the 
dominant release mechanism for poorly soluble drugs, whereas the soluble portion of drug is 
released by diffusion through the gel layer [9, 10, 21-23]. Due to the non-ionic nature of 
hydroxypropyl methylcellulose (HPMC), when drug solubility is pH- independent, the 
matrices also exhibit pH-independent drug releases profiles [24]. The high molecular weight 
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chemistries are the most widely used polymers in ER matrix formulations, e.g., 
METHOCELTM Premium K (hypromellose 2208, USP) and E (hypromellose 2910, USP). 
The HPMC substitution type and molecular weight has an effect on the amount of water 
bound to the polymer [25]. According to Aoki and co-workers [26], during the initial stage of 
dissolution, water penetrates into the matrix and usually acts as non-freezing (bound) water. 
In the next stage, the water content of the matrix increases and freezable water is detected at 
levels that are related to drug release. They also reported that the transport of solutes mainly 
occurs through the free water and that only little transport occurs through bound water. 
Yoshioka and coworkers [27], studied hydrophilic polymeric gelatin gels and claimed that 
bound water did not participate to any significant effect in the hydration process and that the 
hydrolysis/water-uptake rate depended mainly on the amount of free water present in the 
system. Therefore, determining the dynamics and state of water molecules in hydrogels 
enables a better understanding of the swelling process of the hydrophilic matrices and the 
release of drugs from these systems [28].  Three types of hydration water has been reported  
[29] with each possessing different physical properties; Type I (freezing or free, bulk-like 
water) melts at the normal melting point of pure water (0 oC); Type II (freezing or bound 
water) interacts weakly with macromolecules and displays a lower melting point than pure 
water (< 0 oC) and Type III (bound water) which interacts strongly with hydrophilic and ionic 
groups of the polymer and shows non-freezing behaviour.  
Pharmaceutical powders are prone to electrostatic charging because they normally have a 
high electrical resistance, preventing charge dissipation. Triboelectrification is a phenomenon 
which refers to electrostatic charge being generated due to the difference in electrical 
potential when two materials come into contact with each other. The ability to control the 
charging of pharmaceutical powders is essential in improving the quality of the end product 
and minimising powder loss. Triboelectrification is used to help with the mixing operations in 
industry [30, 31] More recently, the triboelectric charging behaviour of E4M, K4M and their 
powder blends with theophylline, were studied. It was shown that when theophylline was 
mixed with hypromellose grades of opposite polarities, the triboelectric charge of the final 
powder mixture was decreased forming a stable ordered mixture believed to result in a more 
homogenous and stable system [32].    
In the present work, three grades of the E chemistry HPMC polymer, and their formulated 
blends were characterised by triboelectrification, particle sizing and particle morphology. 
Theophylline release from these polymers were assessed with varying  agitation sequences, 
ionic strengths and pH levels using the USP III apparatus to discriminate between the 
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performances of the polymers. This study was performed with a view to differentiate between 
poor and robust sustained release formulations. Rheological experiments were also conducted 
to ascertain the influence of the various ionic strengths on the gel layer produced form these 
polymers.   
 
2. Materials and methods 
2.1. Materials 
HPMC E chemistry grades METHOCEL™, E50LV, E4M and E10M supplied by Colorcon 
UK were used as the hydrophilic matrix formers. Anhydrous theophylline was obtained from 
Sigma, UK. Dissolution buffers were prepared according to the USP 2003 [33] using the 
following materials: potassium chloride (Acros Organics, UK) and hydrochloric acid (Fisher 
Scientific, UK) for dissolution media at pH 1.2 and pH 2.2;  potassium phosphate monobasic- 
(Fisher BioReagents, UK) and sodium hydroxide (Fisher Scientific, UK) for dissolution 
media at pH 5.8, 6.8, 7.2 and 7.5 . 
 
2.2. Powder characterisation  
2.2.1. Electrostatic properties of pure polymers and formulated blends 
A triboelectric device based on a shaking concept, previously described by Šupuk and co-
workers [34-36] was used to investigate the triboelectrification of theophylline, the three 
HPMC E chemistry polymers and their formulation blends (the formulation blends were in 
the ratio of 4:1 (drug: HPMC) for 10 min at 100 rpm in a Turbula® mixer. This is further 
detailed in section 2.6) by determining the charge-to-mass ratio. In this work, the charge-to-
mass ratio of the bulk powders was measured after shaking using a custom-made Faraday cup 
connected to an electrometer (Keithley Model 6514). If a positively-charged particle enters 
the Faraday cup, a negative charge is induced and distributed on the inner surface of the 
Faraday cup, whilst a positive charge is distributed over the outer surface of the cup, setting 
up an electric field and a potential difference between the two cups. The capacitance C 
between the inner and outer cups acquires a potential, ܸ ൌ ݍ/ܥ which is measured by an 
electrometer connected to an inner cup.  The charge-to-mass ratio is obtained by dividing the 
net charge measured and the mass of the sample tested. Tests were carried out under ambient 
temperature (22 ºC) and humidity (35 - 47 %RH).  
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2.3. Micromeritic properties of polymers  
2.3.1. Particle size analysis  
Particle size distribution (PSD) analysis was conducted on an aerosolised dry samples of the 
HPMC E50LV, E4M and E10M using a Sympatec (Clausthal-Zellerfeld, Germany) laser 
diffraction particle size analyser as described previously [37].  
 
2.3.2. True density measurements 
The Ultrapycnometer 100 (Quantachrome Instruments) was used in the determination of the 
true density of powder mixtures used for the tableting. The test was carried out using a multi-
run system with a standard deviation of 0.005 %. The results presented are the mean and 
standard deviation of a minimum of three determinations.  
 
2.3.3. Surface area measurements 
Brunauer–Emmett–Teller (BET) surface area was measured by nitrogen adsorption using 
Micromeritics Gemini 6 (Norcross, USA) automated gas sorption system model. The 
determination of external surface area was estimated by using the standard t-plot calculations 
by using experimental points at a relative pressure of P/P0 = 0.1 - 0.5. All measurements 
were done in triplicate. Surface roughness of different polymers tested was calculated based 
on the ratio between BET surface area and theoretical surface area [37]  
 
2.3.4. Water content analysis 
The moisture content of the samples was determined semi-automatically by the Karl Fisher 
method (Metter Toledo, C20 Coulometric KF Titrator, Switzerland). The Fischer reagent 
solution was Hydranal® Coulomat AF (Sigma Aldrich, USA). 
 
2.4. Scanning electron microscopy (SEM) 
Electron micrographs of all polymers were obtained using a scanning electron microscope 
(SEM) (Philips XL 20, Eindhoven, Netherlands) operating at either 2 or 5 kV. The samples 
were mounted on a metal stub with double-sided adhesive tape and coated under vacuum 
with gold in an argon atmosphere prior to observation. Several magnifications (x100 -3000 
magnifications) were used to observe the shape and surface topography of particles of the 
different HPMC grades.  
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2.5. Rheological measurements 
2.5.1 Sample preparation of rheological study 
Two sets of samples were prepared from E50V, E4M and E10M HPMC polymers to make 5 
% w/v into pH 1.2 media (no NaCl) and pH 1.2 media (0.4M NaCl) at 37  ± 0.5 °C. The 
samples were then subjected to rheological measurements to investigate their stiffness and the 
strength of the gel after the swelling process in the media.  All rheological measurements 
were performed using a Bohlin Gemini Nano HR rheometer (Malvern Instruments, 
Worcestershire, UK) fitted with 55 mm parallel-plate geometry. 
 
2.5.2. Yield stress determination 
Stress sweep rheological studies were used to determine yield stress of different gel 
formulations to predict the stress required to initiate erosion. The stress was gradually 
increased from 0.1 Pa to 1000 Pa at 1.5 rad s−1 angular frequency. All measurements were 
taken at 37 ± 0.5 °C. 
 
2.5.3. Frequency Sweep measurement 
The rheological behaviour of the samples was evaluated in terms of the elastic (storage) 
modulus (G′) and the viscous (loss) modulus (G″) as a function of angular frequency (0.1–
100 rad s−1 angular frequency) to produce mechanical spectra of the samples. Measurements 
were taken at 37 ± 0.5 °C and performed at 0.5 % strain (strain amplitude chosen was within 
the linear viscoelastic region of the sample). 
 
2.5.4. Single frequency measurement 
Oscillation mode (single frequency –stress control) was used to determine the viscoelasticity 
of the gel formed after swelling. In order to understand how the elastic modus (G′) of the gel 
was affected by the different HPMC grades, a 5 %w/v of each of the E chemistry HPMC 
grades was dispersed in media at pH 1.2 at 37 ± 0.5 °C and left to hydrate for 1 h before 
rheological measurements were obtained. 
The measurements were recorded at 1.5 rad s−1 angular frequency and 0.5 % strain with a 
0.6 mm gap. The strain amplitude chosen was within the linear viscoelastic region of the 
samples. All measurements were taken at 37 ± 0.5 °C. 
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2.6. Tablet preparation and mechanical strength test 
Round cylindrical tablets with a diameter of 9.6 ± 0.1 mm and the target weight of 250 ± 1 
mg were prepared by blending theophylline with HPMC E50LV, E4M or E10M in the ratio 
of 4:1 for 10 min at 100 rpm in a Turbula® mixer (Type T2 C, Switzerland). The tablets were 
compressed using a single punch-tableting machine (Model MTCM-1, Globe Pharma, US) at 
1500 psi (5.55 kN). The die wall was lubricated each time after tablet compression with a 1 
% w/v suspension of magnesium stearate (Acrõs Organics, New Jersey, USA) in acetone 
(Fisher Scientific, UK). The breaking force for five tablets was determined using Schleuniger 
8M tester (Switzerland). .  
 
2.7. Dissolution test 
2.7.1. Effect of pH and agitation 
Drug release profile of the formulations was investigated in six different dissolution media to 
evaluate the degree of sensitivity of the different methoxyl substitution grades of HPMC to 
pH. A series of buffer solutions that simulated the stomach and intestinal conditions in fasted 
and fed states with the pH values of 1.2, 2.2, 5.8, 6.8, 7.2 and 7.5 were used. The dissolution 
testing was conducted for 310 min for all formulations. The influence of agitation on drug 
release was studied and  detailed in a previous study  [38]. All theophylline-HPMC (E50LV, 
E4M and E10M) formulations were tested using this developed methodology and it 
facilitated the discrimination of the effect of agitation on the formulations where different 
viscosity or molecular weight grades of the HPMC were used.  
 
2.7.2. Influence of ionic strength 
Sodium chloride was used to regulate the ionic strengths of the media from 0 to 0.4 M in 
buffers with pH values of 1.2, 2.2, 5.8, 6.8, 7.2 and 7.5. The ionic strength of the fluids of the 
GI tract in man under both fasted and fed states and various physiological pH conditions 
cover a range of 0 - 0.4 M [39]. Sodium chloride is the mid-range of the lyotropic series and 
has the ability to salt out polymers, hence is often used as the agent for ionic regulation of 
dissolution media [39, 40]. Both theophylline E50LV, E4M and E10M formulations were 
tested by varying  ionic strength of the dissolution media as reported by Asare-Addo et al. 
[41]. The absorbance of the released theophylline was measured at 271 nm using a 
UV/Visible spectrophotometer (Varian, Cary 50). 
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2.8. Similarity factor 
Similarity factor was calculated as detailed in Asare-Addo et al. [38, 42] for the effect of 
agitation. Drug release in water was used in the determination of f2 values where ionic 
strength was concerned as detailed in Asare-Addo et al., [41] f2 values above 50 is an 
indication of similarity, while  less than 50 indicates dissimilarity between two dissolution 
profiles [43].  
 
2.9. Dissolution parameters 
The mean dissolution time (MDT), which is the mean time for the drug to dissolve under in-
vitro dissolution conditions, is a model-independent method and is suitable for dosage forms 
that exhibit  different mechanisms of drug release [39, 44]. As this study uses different 
viscosities of HPMC polymers, it provides a way of comparing the dissolution profiles. The 
dissolution efficiency (DE) and mean dissolution rates (MDR) were also calculated. The 
equations for the calculation of these dissolution parameters are detailed elsewhere [45].  
 
2.10. Kinetics of drug release  
The kinetics of drug release was analysed using Peppas equation [46] as detailed in a 
previous study  [38]. In general for drug release from films [46], n values close to 0.5 are 
indicative of the drug release being primarily by diffusion. Values of n = 1 gives an 
indication that drug is released by relaxation and erosion processes. Anomalous transport is 
the term given to n values between 0.5 and 1. This is an indicator of the superposition of both 
processes. However, for the tablet matrices which are cylindrical in shape, the n values are 
slightly different as derived by [46] Values of n of up to 0.45 suggest Fickian diffusion, and 
values above 0.89 suggest Case-II transport. Values between these two suggest the 
occurrence of anomalous transport.  
 
2.11. Differential Scanning Calorimetry (DSC) 
Part A:  
Samples of physical mixtures of drug and polymer after the mixing process in section 2.6 
were placed in standard 40 µL aluminium crucibles and sealed.  The aluminum pans were 
heated (from 25 oC to 300 oC at 10 oC/min under nitrogen gas) to examine potential drug 
interactions.  
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Part B:  
Flat-faced 4 mm disks with target weights of 20 mg each were produced from all four 
theophylline-HPMC (E50LV, E4M and E10M) mixtures and compressed using a single 
punch tableting machine (Model MTCM-1, Globe Pharma, US) at 1500 psi (5.55 kN). The 
die wall was lubricated each time after tablet compression with a 1 % w/v suspension of 
magnesium stearate in acetone. The discs were hydrated for 5, 10, 15 and 20 min using 
purified water, pH 1.2, pH 1.2 (0.2 M ionic strength) and pH 1.2 (0.4 M ionic strength), 
placed in standard aluminium pans and sealed with a lid. The aluminium pans were firstly 
cooled from ambient temperatures (~25 oC) to -30 oC at 55 oC/min, to freeze any unbound 
(free) water; maintained at -30 oC for 5 minutes for equilibration and then heated from -30 oC 
to 50 oC at 10 oC/min under nitrogen gas to determine amount of free and bound water and 
hydration rate of the tablets using endothermic scanning of the melted free water [41, 47].  
These experiments were carried out in triplicate. 
 
3. Results and discussion 
3.1. HPMC polymer and formulation characterization 
Triboelectrification experiments were performed to evaluate charging and adhesion 
behaviour of theophylline on addition of different HPMC polymers. The charge test for 
theophylline on its own indicated that the saturated charge is –23nC/g after shaking for two 
minutes (Table 1). The level of charge is relatively low compared to common API charge as 
reported previously [48]. Triboelectrification of polymers shows E4M to be charged 
positively against the stainless steel container, whilst E10M and E50LV both had slight 
electronegative charges. The magnitude of charge of E4M was notably higher than E10M and 
E50LV. In general, it was shown that the negative charge of theophylline decreased after 
blending with HPMC polymers. Theophylline charged negatively as did the blends, but the 
magnitude was reduced due to the presence of HPMC polymer in the blends. The charge 
generated by a material depends entirely on contact between surfaces. Generally, particulates 
that are fine tend to charge negatively. Larger particles on the other hand tend to charge 
positively. A hypothetical mechanism for particle size dependent charging was provided by 
Lacks and Levandovsky, [49]. It has been argued that collisions allow electrons trapped in 
high-energy states on one particle to transfer to the vacant low-energy states on another 
particle assuming that the surface density of trapped electrons is initially the same on all 
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particles [50, 51]. Therefore, as HPMC polymer is blended with theophylline, the charge that 
is measured is mainly that of the polymer despite the drug being in excess (by weight). All 
powder blends had similar adhesion to the walls of the vessel, irrespective of the chemistry or 
molecular weight of the polymer (p > 0.05).  
E chemistry polymers demonstrated different physical properties as summarized in Table 1. 
The mean diameter ranged between 72.7 ± 0.2 and 81.9 ± 0.3 µm, which was further 
qualitatively confirmed by SEM images (Supplementary figure 1).  E4M had the largest 
particle size with the narrowest size distribution (as indicated by the smallest span), the 
highest specific surface area and the roughest surface texture. On the other hand, E50LV 
showed the smallest size with widest size distribution, the smallest specific surface area and 
the smoothest surface texture among polymers tested (Table 1). The E chemistry polymers 
also had a water content range between 3.4 and 3.7 %w/w. The E chemistry 4:1 drug:HPMC 
formulations showed that they are robust formulations in terms of tablet hardness (50-76 kN). 
The rank order breaking force or mechanical strength of the E chemistry HPMC tablet 
matrices was E10M > E50LV > E4M. 
3.2. Effect of agitation 
Figure 1a shows the influence of agitation rate and sequence on drug release from tablets that 
contain the E chemistry HPMC grades. For matrices containing the low viscosity polymer 
E50LV, once in water with the applied agitation, fragments of the tablet were detaching from 
the matrix surface into the solution before a full gelatinous layer was formed, although none 
of the tablets actually disintegrated. Drug release increased with an increase in the agitation 
rate. Drug release rate was in the order of E50LV > E4M > E10M (For E4M and E10M, refer 
to Supplementary figure 2). This showed that the erosion occurring because of the increased 
agitation rate was more rapid for the HPMC with the lower molecular weight, which in this 
case was the E50LV. This could be explained as follows; The gel being formed on the 
surface of the tablet upon its introduction into media could limit the amount of drug being 
transported into the solution as drug moved from one medium condition to another and the 
change in the tablets geometry as a result of agitation meaning a decreased surface area for 
the next medium. The E10M tablet matrices however as compared to the E4M and E50LV 
tablet matrices was less prone to the effects of agitation due to its high elasticity G’ hence, 
higher stress required to yield (Figure 5) [38]. 
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A comparison of the two different agitations rates in the ascending order of 5-30 dpm and 
descending order of 30-5 dpm confirmed the susceptibility of the E50LV tablet matrices to 
the effects of agitation. All drug was released in pH 2.2 medium after just 120 min in the 
descending form of agitation (30-5 dpm) (Figure 2a). In the case of E4M matrices, the entire 
drug was released in pH 7.2 medium after 280 min with a starting agitation of 30 dpm, with 
75 % of the drug released in pH 1.2 alone. When agitation was started at 5 dpm, 76 % of the 
drug was released after 310 min in pH 7.5 (Supplementary figure 3). The E10M showed 
resilience after the dissolution process of 310 min with a drug release of 77 % in the 
ascending order of agitation (5-30 dpm) and 89 % in the descending order (30-5 dpm) in pH 
7.5 (Figure 2b). These results show that drug release can vary at different pHs for non-ioinc 
polymers depending on the agitation rate and molecular weight of polymers. For example, for 
formulations that are not robust, the agitation could cause a relatively fast drug release 
resulting in a possible toxicity or making a drug unavailable at the targeted site [32, 52] . The 
generally fast rate of drug release from the tablet matrices rendered most of the dissolution 
profiles dissimilar or impossible to calculate (Table 2). Anomalous transport was the only 
mechanism of drug release from the E50LV tablet matrices (Table 2). The E4M and E10M 
tablet matrices on the other hand were dominated by Fickian diffusion with anomalous 
transport occurring over the increasing order of agitation (5-30 dpm) with respective values 
of 0.50 and 0.47 (Table 2). 
3.3. Effect of ionic strength 
Figure 3 a and supplementary figures 4 a and b shows the impact of ionic strength on drug 
release from E50LV, E4M and E10M tablet matrices respectively with supplementary figure 
5 showing the drug release rates. The ionic strength of buffers used to control pH varied from 
0.05-0.14 M. The addition of 0.2 M and 0.4 M sodium chloride means the actual ionic 
concentration strength at the 0.2 M level ranged between 0.25-0.34 M and for the 0.4 M 
ranged between 0.45-0.54 M but for consistency, the ionic strength of the added NaCl is used 
in legends.  
Similarity calculations were not valid for release of theophylline from the E50LV (Table 3). 
This was a result of the quick drug release from its matrices thereby not having enough time 
points for a valid analysis. With regards to the E4M tablet matrices, similarity was only 
obtained in the pH media with an f2 value of 95. The E10M tablet matrix was the most robust 
of the formulations. Despite the fall in the f2 parameter as ionic strength increased, release 
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profiles were similar at different ionic strengths with f2 values of 63 and 50 in pH-controlled 
media of ionic strengths 0.2 and 0.4 M respectively (Table 3). At pH 1.2 only, drug release 
from E50LV tablet matrices increased after 1 hour from 64.76 + 0.79 % in deionised water to 
76.14 + 1.86 % when ionic strength was increased to 0.4 M. 66.51 + 2.66 % and 65.87 + 2.24 
% of drug had been released from the tablet matrices for the E4M formulation in deionised 
water or pH1.2 medium without added salt (Figure 3b). Upon 0.2 and 0.4 M NaCl, drug 
release from tablet matrices increased to 83.65 + 7.48 % and 83.08 + 5.02 % respectively. 
This significant increase was not reproduced for drug release from the E10M tablet. 50.72 + 
5.58 % of drug was released in deionised water, increasing to 56.42 + 4.01 % on addition of 
0.2 M NaCl and a further increase occurred with 0.4 M NaCl (Figure 3b). At the low ionic 
strengths (buffers with no added salt), the polymer hydration seems to be unaffected. Higher 
ionic strengths however may have led to a loss of gel integrity of the E50LV and E4M 
matrices hence the increase and difference in their drug release profiles. The E10M was thus 
more resilient to the influence of ionic strength in comparison to the E50LV and E4M 
formulations due to its increased viscosity. The results show that despite HPMC being a non-
ionic polymer, the medium ionic composition can influence its behaviour drug release 
behaviour. This was in agreement with work done by Kavanagh and Corrigan [53]. They 
showed that an increase in ionic strength brought about a decrease in matrix erosion rate with 
the phenomenon being prevalent in low molecular weight HPMC grades. Alderman [54] also 
noted that as the ionic strength of the medium increases, the polymer molecular chains loose 
water of hydration due to ions competing for the available water. 
MDTs generally decreased with increasing ionic strength for all matrices. The E50LV tablet 
matrix exhibited anomalous transport in deionised water and buffers, with Fickian kinetics 
becoming more dominant with increasing ionic strength (Table 3). Fickian release dominated 
for all E4M and E10M formulations.  
3.4 Evaluation of gel strength of HPMC polymer 
It has been observed that the different HPMC grades show different drug release behaviour. 
In order to clarify these findings, the rheological properties of the polymers used were 
determined by oscillatory rheometry. The stiffness and degree of inter-particle interaction 
were evaluated by stress sweep rheological measurements. Figure 4a shows the yield stress 
and gel strength for different HPMC grades. The yield stress can be inferred from the stress at 
which G’ starts to decrease. The stress required to yield or to erode were 1 Pa, 150 Pa, and 
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320 Pa, for the E50 LV, E4M and E10M respectively. This result indicates a high degree of 
inter-particle interactions which suggests a lower degree of erosion for E10M [55, 56]. The 
stiffness of the gel was also found to be varied from 2.5 Pa, 176.2 Pa and 408.3 Pa for the 
E50LV, E4M and E10M respectively. The lower G’ value can be explained by a softer gel 
being formed after tablet introduction into the dissolution media. The reduction in stiffness of 
the gel indicates faster drug release [57]. Figure 4b and supplementary figure 6a and b shows 
elastic modulus G’ and viscous modulus G’’ versus frequency sweep oscillation for E50LV, 
E4M and E10M. E50LV, E4M and E10M exhibit similar classical temporary network 
response with G” Greater than G’ at low frequencies, indicating that the polymer behaves as a 
viscous liquid. By increasing the frequency G’ increased and G’’ decreased gradually until 
they crossed over at the critical gel point frequency (indicated by black arrow). At higher 
frequencies, G’ becomes greater than G’’ indicating that the polymer behaves as a more 
elastic material [58]. The observed difference in both moduli for different HPMC grade is 
normal since polymers with higher molecular weight increase the entanglement density [59]. 
E10M had the strongest G’ and G’’ with 1.4 Pa frequency to get to gel critical point 
indicating that E10M is more elastic [58, 59]. There is a poor evidence of gel formation in 
figure 4b. Therefore E50LV system is more susceptible to erosion and/or dilution during drug 
release study [59]. Talukdar et al. reported no detectable influence of the ionic strength of the 
medium on the rheological properties of HPMC [59]. This is in good agreement with the 
present study, as shown in figure 5a and b. There was no significant difference (P > 0.05) in 
yield stress figure 5a and G’ figure 5b of the same HPMC grade samples treated with the two 
different ionic strength solutions (pH 1.2 media (no NaCl) and pH 1.2 media (0.4M NaCl)), 
this may be due to non-ionic charge of HPMC polymer. This result thus explained the 
independence of drug release in different ionic strength media.  
 
3.4. DSC analysis 
DSC traces showed no material interaction between the drug, theophylline, and the HPMC 
polymers (Figure not included). DSC hydration showed the E50LV tablet matrices to 
generally have more bound water compared to the E4M and E10M tablet matrices 
(Supplementary figure 7) suggesting that it would be more prone to food effects and that the 
penetration of the various media into the matrix used happened more quickly [41]. All 
polymers showed an increase in bound water with the increase in ionic strength thus agreeing 
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with findings for bound and free water states in K chemistry HPMC matrices [41]. As the 
ratio of bound water to free water increases, the amount of water available for polymer 
hydration is reduced thereby the gel layer for controlling drug release is somewhat 
compromised. Yoshioka et al.  [27] and Aoki et al. [26] showed that bound water did not 
contribute significantly to drug release and that water uptake by hydrophilic matrices was 
dependant on the amount of free water present in the system. The amount of drug released at 
the 10 min time point also correlated with the DSC hydration experiments as in [41]. The 
theophylline release increased with an increase in the ionic concentration strength. In the 
highest ionic concentration strength medium, the amount of bound water was similar for all 
the formulations tested suggesting that the strength of the gel played an important role also in 
the drug release pattern as also in [41]. 
4. Conclusion 
HPMC E50LV particles were of a smaller size, smaller surface area and smoother surfaces 
than E4M and E10M grades of HPMC. The polymers E4M, E10M and E50LV are effective 
in dissipating electrostatic charge of the API. Drug release from E50LV and E4M matrices 
was affected by changing agitation and ionic strength. With regards to agitation, there was an 
increase in drug release with an increase in agitation. Ascending and descending rates of 
agitation were used to differentiate between all three formulations and showed the E10M 
tablet matrices to be more resilient to the impact of agitation. Incremental increases in ionic 
strength also had a profound effect on the E50LV and E4M tablet matrices. This could be 
attributed to the fact that an increase in the ion concentration in a polymer solution decreases 
the solubility or hydration of the polymer thereby reducing the amount of available water for 
hydrating the polymer. Rheological evaluation of the gels indicated a high degree of inter-
particulate interactions which can suggest a lower degree of erosion for E10M as compared to 
the other polymers. The E10M polymer was also resilient to the influence of ionic strength. 
DSC studies on the hydration states also proved useful in explaining drug release from the E-
chemistry HPMC polymers. This highlights the importance of choosing the right HPMC 
polymer for the extended release matrix.  
 
5. Acknowledgements 
The authors are grateful to Colorcon for the free gift of hypromellose and to the University of 
Huddersfield for funding this research. 
  16 
 
 
References  
[1] F. Lotfipour, A. Nokhodchi, M. Saeedi, S. Norouzi-Sani, J. Sharbafi, M.R. Siahi-
Shadbad, The effect of hydrophilic and lipophilic polymers and fillers on the release rate of 
atenolol from HPMC matrices, Farmaco, 59 (2004) 819 
[2] S. Takka, S. Rajbhandari, A. Sakr, Effect of anionic polymers on the release of 
propranolol hydrochloride from matrix tablets, Eur. J. Pharm. Biopharm., 52 (2001) 75 
[3] C.G. Cameron, J.W. McGinit, Controlled-Release Theophylline Tablet Formulations 
Containing Acrylic Resins, II. Combination Resin Formulations, Drug Dev. Ind. Pharm., 13 
(1987) 1409 
[4] G.S. Rekhi, R.V. Nellore, A.S. Hussain, L.G. Tillman, H.J. Malinowski, L.L. Augsburger, 
Identification of critical formulation and processing variables for metoprolol tartrate 
extended-release (ER) matrix tablets, J. Control. Release, 59 (1999) 327. 
[5] M.A. Vandelli, E. Leo, F. Foni, M.T. Bernabei, Drug release from perforated matrices 
containing hydroxypropylcellulose, Int. J. Pharm., 171 (1998) 165. 
[6] B. Saša, P. Odon, S. Stane, K. Julijana, Analysis of surface properties of cellulose ethers 
and drug release from their matrix tablets, Eur. J. Pharm. Sci., 27 (2006) 375. 
[7] M.R. Siahi-Shadbad, K. Asare-Addo, K. Azizian, D. Hassanzadeh, A. Nokhodchi, 
Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium 
powder in combination with hydrophilic polymers, AAPS PharmSciTech, 12 (2011) 1176 
[8] K. Asare-Addo, A.O. Adebisi, A. Nokhodchi, Agitation Sequence and Ionic Strength on 
In-Vitro Drug Release from Hypromellose–The Influence of Compaction Force, Int Journal 
of Basic Medical Sciences and Pharmacy (IJBMSP), 5 (2015) 1 
[9] B. Abrahamsson, K. Roos, J. Sjogren, Investigation of prandial effects on hydrophilic 
matrix tablets, Drug Dev. Ind. Pharm., 25 (1999) 765 
[10] W. Phuapradit, S. Bolton, The influence of tablet density on the human oral absorption 
of sustained release acetaminophen matrix tablets, Drug Dev. Ind. Pharm., 17 (1991) 1097 
[11] L.E. Schmidt, K. Dalhoff, Food-drug interactions, Drugs, 62 (2002) 1481 
  17 
[12] J. Nekvindova, P. Anzenbacher, Interactions of food and dietary supplements with drug 
metabolising cytochrome P450 enzymes, Ceska Slov. Farm., 56 (2007) 165 
[13] R. Bushra, N. Aslam, A.Y. Khan, Food-Drug Interactions, Oman Med. J., 26 (2011)  
[14] N. Washington, C. Wilson, Physiological Pharmaceutics Ellis Horwood Ltd, Chichester, 
1989 
[15] W.N. Charman, C.J. Porter, S. Mithani, J.B. Dressman, Physiochemical and 
physiological mechanisms for the effects of food on drug absorption: the role of lipids and 
pH, J. Pharm. Sci., 86 (1997) 269 
[16] M.C. Bonferoni, S. Rossi, F. Ferrari, M. Bertoni, C. Caramella, Influence of medium on 
dissolution-erosion behaviour of Na carboxymethylcellulose and on viscoelastic properties of 
gels, Int. J. Pharm., 117 (1995) 41 
[17] A.C. Hodsdon, J.R. Mitchell, M.C. Davies, C.D. Melia, Structure and behaviour in 
hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-
release performance and internal gel structure of sodium alginate matrices, J. Control. 
Release, 33 (1995) 143 
[18] J.L. Johnson, J. Holinej, M.D. Williams, Influence of ionic strength on matrix integrity 
and drug release from hydroxypropyl cellulose compacts, Int. J. Pharm., 90 (1993) 151 
[19] A. Nokhodchi, S. Raja, P. Patel, K. Asare-Addo, The role of oral controlled release 
matrix tablets in drug delivery systems, BioImpacts : BI, 2 (2012) 175 
[20] A. Nokhodchi, K. Asare-Addo, Drug release from matrix tablets: physiological 
parameters and the effect of food, Expert Opin Drug Deliv, 11 (2014) 1401 
[21] B. Abrahamsson, D. Johansson, A. Torstensson, K. Wingstrand, Evaluation of 
solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of 
felodipine, Pharm. Res., 11 (1994) 1093 
[22] J.W. Skoug, M.V. Mikelsons, C.N. Vigneron, N.L. Stemm, Qualitative evaluation of the 
mechanism of release of matrix sustained release dosage forms by measurement of polymer 
release, J. Control. Release, 27 (1993) 227 
  18 
[23] W.D. Lindner, B.C. Lippold, Drug release from hydrocolloid embeddings with high or 
low susceptibility to hydrodynamic stress, Pharm. Res., 12 (1995) 1781 
[24] A. Nokhodchi, D. Palmer, K. Asare-Addo, M. Levina, A. Rajabi-Siahboomi, 
Application of Polymer Combinations in Extended Release Hydrophilic Matrices, in:  
Handbook of Polymers for Pharmaceutical Technologies, John Wiley & Sons, Inc., 2015, pp. 
23 
[25] C.B. McCrystal, J.L. Ford, A.R. Rajabi-Siahboomi, A study on the interaction of water 
and cellulose ethers using differential scanning calorimetry, Thermochimica Acta, 294 (1997) 
91 
[26] S. Aoki, H. Ando, M. Ishii, S. Watanabe, H. Ozawa, Water behavior during drug release 
from a matrix as observed using differential scanning calorimetry, J. Control. Release, 33 
(1995) 365 
[27] S. Yoshioka, Y. Aso, T. Terao, Effect of water mobility on drug hydrolysis rates in 
gelatin gels, Pharm. Res., 9 (1992) 607 
[28] S. Baumgartner, G. Lahajnar, A. Sepe, J. Kristl, Investigation of the state and dynamics 
of water in hydrogels of cellulose ethers by(1)H NMR spectroscopy, AAPS PharmSciTech, 3 
(2002) 86 
[29] M.S. Jhon, J.D. Andrade, Water and hydrogels, J. Biomed. Mater. Res., 7 (1973) 509 
[30] B.H. Kaye, Powder Mixing, 1 ed., Chapman & Hall, London, UK 1997. 
[31] J. Staniforth, J. Rees, Powder mixing by triboelectrification, Powder Tech 30 (1981) 255 
[32] K. Asare-Addo, W. Kaialy, M. Levina, A. Rajabi-Siahboomi, M.U. Ghori, E. Supuk, 
P.R. Laity, B.R. Conway, A. Nokhodchi, The influence of agitation sequence and ionic 
strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of 
the USP III apparatus, Colloids Surf B Biointerfaces, 104 (2013) 54 
[33] U.S.P. Convention, The United States Pharmacopoeia USP 26-the National Formulary 
NF21: By Authority of the United States Pharmacopeial Convention, Inc., Meeting at 
Washington, D.C., April 12-16, 2000, United States Pharmacopeial Convention, 2003. 
  19 
[34] E. Šupuk, C. Seiler, M. Ghadiri, Analysis of a Simple Test Device for Tribo-Electric 
Charging of Bulk Powders, Particle & Particle Systems Characterization, 26 (2009) 7 
[35] E. Supuk, M.U. Ghori, K. Asare-Addo, P.R. Laity, P.M. Panchmatia, B.R. Conway, The 
influence of salt formation on electrostatic and compression properties of flurbiprofen salts, 
Int. J. Pharm., 458 (2013) 118 
[36] K. Asare-Addo, E. Supuk, H. Al-Hamidi, S. Owusu-Ware, A. Nokhodchi, B.R. Conway, 
Triboelectrification and dissolution property enhancements of solid dispersions, Int. J. 
Pharm., 485 (2015) 306 
[37] W. Kaialy, T. Hussain, A. Alhalaweh, A. Nokhodchi, Towards a More Desirable Dry 
Powder Inhaler Formulation: Large Spray-Dried Mannitol Microspheres Outperform Small 
Microspheres, Pharm. Res., 31 (2014) 60 
[38] K. Asare-Addo, M. Levina, A.R. Rajabi-Siahboomi, A. Nokhodchi, Study of dissolution 
hydrodynamic conditions versus drug release from hypromellose matrices: the influence of 
agitation sequence, Colloids Surf B Biointerfaces, 81 (2010) 452. 
[39] X. Mu, M.J. Tobyn, J.N. Staniforth, Influence of physiological variables on the in vitro 
drug-release behavior of a polysaccharide matrix controlled-release system, Drug Dev. Ind. 
Pharm., 29 (2003) 19. 
[40] K. Mitchell, J.L. Ford, D.J. Armstrong, P.N.C. Elliott, C. Rostron, J.E. Hogan, The 
influence of additives on the cloud point, disintegration and dissolution of 
hydroxypropylmethylcellulose gels and matrix tablets, Int. J. Pharm., 66 (1990) 233. 
[41] K. Asare-Addo, M. Levina, A.R. Rajabi-Siahboomi, A. Nokhodchi, Effect of ionic 
strength and pH of dissolution media on theophylline release from hypromellose matrix 
tablets—Apparatus USP III, simulated fasted and fed conditions, Carbohydrate Polymers, 86 
(2011) 85. 
[42] J.W. Moore, H.H. Flanner, Mathematical comparison of dissolution profiles Pharma 
Tech 20 (1996) 64 
[43] J.E. Polli, G.S. Rekhi, L.L. Augsburger, V.P. Shah, Methods to compare dissolution 
profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets, J. 
Pharm. Sci., 86 (1997) 690. 
  20 
[44] K.A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol., 27 (1975) 48. 
[45] H. Al-Hamidi, A.A. Edwards, D. Douroumis, K. Asare-Addo, A.M. Nayebi, S. Reyhani-
Rad, J. Mahmoudi, A. Nokhodchi, Effect of glucosamine HCl on dissolution and solid state 
behaviours of piroxicam upon milling, Colloids Surf B Biointerfaces, 103 (2013) 189. 
[46] J. Siepmann, N. Peppas, Mathematical modeling of controlled drug delivery, Adv Drug 
Del Rev, 48 (2001) 137. 
[47] W. Kaialy, P. Emami, K. Asare-Addo, S. Shojaee, A. Nokhodchi, Psyllium: a promising 
polymer for sustained release formulations in combination with HPMC polymers, Pharm. 
Dev. Technol., 19 (2014) 269. 
[48] E. Šupuk, A. Zarrebini, J.P. Reddy, H. Hughes, M.M. Leane, M.J. Tobyn, P. Timmins, 
M. Ghadiri, Tribo-electrification of active pharmaceutical ingredients and excipients, Powder 
Tech, 217 (2012) 427. 
[49] D. J. Lacks and A. Levandovsky, Effect of particle size distribution on the polarity of 
triboelectric charging in granular insulator systems, J Electrostat, 65 (2007) 107–112. 
[50] W. Kaialy, A review of factors affecting electrostatic charging of pharmaceuticals and 
adhesive mixtures for inhalation, Int J Pharm. (2016) In press. doi: 
10.1016/j.ijpharm.2016.01.076 
[51] A. O. Adebisi, W. Kaialy, T. Hussain, H. Al-Hamidi, A. Nokhodchi, B. R. Conway, K. 
Asare-Addo, An assessment of triboelectrification effects on co-ground solid dispersions of 
carbamazepine, Powder Tech, 292, (2016). 342. 
[52] K. Asare-Addo, B.R. Conway, H. Larhrib, M. Levina, A.R. Rajabi-Siahboomi, J. Tetteh, 
J. Boateng, A. Nokhodchi, The effect of pH and ionic strength of dissolution media on in-
vitro release of two model drugs of different solubilities from HPMC matrices, Colloids Surf 
B Biointerfaces, 111 (2013) 384. 
[53]  N. Kavanagh, O.I. Corrigan, Swelling and erosion properties of 
hydroxypropylmethylcellulose (Hypromellose) matrices - Influence of agitation rate and 
dissolution medium composition, Int J Pharm, 279 (2004), 141 
  21 
[54] D.A. Alderman, A review of cellulose ethers in hydrophilic matrices for oral controlled-
release dosage forms, International Journal of Pharmaceutical Technology and Product 
Manufacture, 5 (1984), 1 
[55] M.H. Mahdi, B.R. Conway, A.M. Smith, Development of mucoadhesive sprayable 
gellan gum fluid gels, Int. J. Pharm., 488 (2015) 12. 
[56] I. Fernández Farrés, I.T. Norton, The influence of co-solutes on tribology of agar fluid 
gels, Food Hydrocolloids, 45 (2015) 186. 
[57] M.H. Mahdi, B.R. Conway, A.M. Smith, Evaluation of gellan gum fluid gels as 
modified release oral liquids, Int. J. Pharm., 475 (2014) 335. 
[58] T. Hoare, D. Zurakowski, R. Langer, D.S. Kohane, Rheological blends for drug delivery. 
I. Characterization in vitro, Journal of biomedical materials research. Part A, 92 (2010) 575. 
[59] M.M. Talukdar, I. Vinckier, P. Moldenaers, R. Kinget, Rheological characterization of 
xanthan gum and hydroxypropylmethyl cellulose with respect to controlled-release drug 
delivery, J. Pharm. Sci., 85 (1996) 537. 
  
  22 
Figure captions  
Figure 1 - The effect of rate and order of agitation on drug release from HPMC (a) E50LV 
tablet matrix formulations (SD, n=3) (b) Drug release rates of the E chemistry tablet 
formulations with respect to the differing agitations. Standard deviations were smaller than 
the symbol size and as such were not shown here. 
 
Note:  
Ascending order of agitation is depicted as 5 - 30 dpm and is when agitation was increased by 5 dpm every time 
the cylinder containing the drug moved from one vial to the other. Thus, in pH 1.2 agitation was 5 dpm, in pH 
2.2 - 10 dpm, in pH 5.8 - 15 dpm, in pH 6.8 - 20 dpm, in pH 7.2 - 25 dpm and in pH 7.5 - 30 dpm.  
Descending order of agitation is depicted as 30 - 5 dpm and is when agitation was decreased by 5 dpm every 
time the cylinder containing the drug moved from one vial to the other. Thus, in pH 1.2 agitation was 30 dpm, in 
pH 2.2 - 25 dpm, in pH 5.8 - 20 dpm, in pH 6.8 - 15 dpm, in pH 7.2 - 10 dpm and in pH 7.5 - 5 dpm [20] 
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Figure 2 - The amount of drug released (%) from HPMC (a) E50LV (b) E10M tablet matrix 
formulations when increasing the agitation rate during the dissolution test (SD, n=3).  
 
Note:  
*Ascending order of agitation; agitation was increased by 5 dpm every time the cylinder containing the drug 
moved from one vial to the other. Thus, in pH 1.2 agitation was 5 dpm, in pH 2.2 - 10 dpm, in pH 5.8 - 15 dpm, 
in pH 6.8 - 20 dpm, in pH 7.2 - 25 dpm and in pH 7.5 - 30 dpm. 
 **Descending order of agitation; agitation was decreased by 5 dpm every time the cylinder containing the drug 
moved from one vial to the other. Thus, in pH 1.2 agitation was 30 dpm, in pH 2.2 - 25 dpm, in pH 5.8 - 20 
dpm, in pH 6.8 - 15 dpm, in pH 7.2 - 10 dpm and in pH 7.5 - 5 dpm [20]. 
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Figure 3 -The effect of ionic strength on drug release from HPMC (a) E50LV tablet matrix 
formulations (b) Amount of drug released from E chemistry HPMC tablet matrices 
formulations after 1 hour in media of varying ionic strengths (SD, n=3) 
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Figure 4 -  Stress sweep for at 1.5 HZ for 5% HPMC as a function of different HPMC grade, 
E10M, E4M and E50LV (a) Elastic (G’ unfilled symbols) and viscous (G’’ filled symbols) 
moduli as a function of frequency for E50LV (circle symbols) (b)  
 
  
  26 
Figure 5 - Yield stress measurement at 37 °C for E50LV, E4M and E10M, dispersed in 
different ionic strength medium (a) Elastic modulus measurement at 37 °C for E50LV, E4M 
and E10M dispersed in different ionic strength medium (b) (SD, n=3).   
 
  
0
50
100
150
200
250
300
350
400
E50 LV E4M E10M
Y
ie
ld
 St
re
s
s (
P
a
)
0.4M HCl
0.0M HClpH 1.2 
(no NaCl)
pH 1.2 
(0.4M 
NaCl)
(a)
0
2.5
5
E50 LV
Y
ie
ld
 S
tr
e
ss
 (P
a
)
0
50
100
150
200
250
300
350
400
E50 LV E4M E10M
G
' (
P
a
)
0.4M HCl
0.0M HClpH 1.2 
(no NaCl)
pH 1.2 
(0.4M 
NaCl)
(b)
0
10
20
E50 LV
G
' (
P
a
)
  27 
Table 1: Tribo-electric properties of HPMC polymers, theophylline and their powder blends 
and Volume mean diameter (VMD), span, BET surface area, roughness, true density and 
water content, for E4M, E10M and E50LV HPMC polymers (SD, n=3) 
Powders and 
Blends 
Charge Adhesion 
VMD  Span 
BET surface 
area  Roughness 
True 
density  
Water 
content   
Qsat 
(nC/g) *Adh (%)  (µm) (m2/g) (g/cm3)  (%) 
Theophylline 
-23.1 + 
0.8 
15.0 + 
2.3 - - - - - - 
E4M 
26.9 + 
5.38 
17.9 + 
2.0 
81.9 ± 
0.3 
1.4 ± 
0.0 0.26 ± 0.02 1.30 ± 0.11 1.35 ± 0.01 3.7 
E10M -5.2 + 1.0 
12.1 + 
0.6 
77.3 ± 
0.5 
1.6 ± 
0.0 0.24 ± 0.02 1.12 ± 0.07 1.37 ± 0.01 3.4 
E50LV -1.5 + 0.4 9.9 + 1.3 
72.7 ± 
0.2 
1.7 ± 
0.0 0.14 ± 0.02 0.72 ± 0.13 1.36 ± 0.01 3.7 
E4M Blend -4.0 + 0.2 
15.9 + 
0.2 - - - - - - 
E10M Blend -5.0 + 0.7 
16.4 + 
1.3 - - - - - - 
E50LV 
Blend -5.1 + 0.2 
16.6 + 
0.6 - - - - - - 
 
*Adh is the powder particles adhered to the walls of the shaking container. 
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Table 2:  Effect of agitation rate on similarity factor (f2) and mechanism of drug release for 
formulated tablets 
Tablet Formulation Agitation RSQ n f2 
E50LV 5 0.9856 0.5816 51 
E50LV 10 0.9742 0.5892 n/a 
E50LV 15 0.9894 0.6659 - 
E50LV 20 0.9909 0.557 - 
E50LV 30 0.9883 0.6036 - 
E50LV 5-30 0.9937 0.7484 52 
E50LV 30-5 0.9877 0.5855 - 
E4M 5 0.9873 0.4001 44 
E4M 10 0.9913 0.2779 n/a 
E4M 15 0.9803 0.2353 - 
E4M 20 0.9888 0.2387 55 
E4M 30 0.9835 0.2148 - 
E4M 5-30 0.9977 0.503 31 
E4M 30-5 0.9834 0.2027 - 
E10M 5 0.9929 0.3794 54 
E10M 10 0.9939 0.324 n/a 
E10M 15 0.9945 0.2601 50 
E10M 20 0.9922 0.2854 48 
E10M 30 0.9922 0.2507 36 
E10M 5-30 0.9971 0.465 60 
E10M 30-5 0.9764 0.2235 34 
 
Note:  n/a as release profile at 10 dpm used as reference 
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Table 3: Similarity factor (f2) and release parameters for tablet matrices 
Drug-release characteristics  
Tablet 
Formulation 
Ionic 
strengths 
Agitation 
 (dpm) 
DE310min 
(%) 
MDT  
(min) 
MDR 
(%min-1) 
RSQ  
(r2) n 
f2 
E50LV 
 
Water (0) 20 85.72 39.43 0.28 0.9886 0.6733 n/a 
(no salt) 20 85.62 36.48 0.26 0.9909 0.5570 - 
(+0.2 M salt) 20 87.46 29.04 0.20 0.9941 0.3705 - 
(+0.4 M salt) 20 89.79 23.06 0.16 0.9900 0.2515 - 
E4M 
 
Water (0) 20 81.58 21.18 0.14 0.9935 0.2686 n/a 
(no salt) 20 79.40 21.44 0.14 0.9888 0.2387 95 
(+0.2 M salt) 20 91.59 16.97 0.11 0.9577 0.1388 - 
 (+0.4 M salt) 20 91.44 15.09 0.09 0.9786 0.1245 - 
E10M 
 
Water (0) 20 65.59 23.05 0.13 0.9927 0.3121 n/a 
(no salt) 20 66.55 22.65 0.13 0.9922 0.2854 82 
(+0.2 M salt) 20 68.36 20.16 0.11 0.9949 0.2387 63 
 (+0.4 M salt) 20 77.35 16.84 0.11 0.9848 0.2677 50 
 
Note:  n/a as release profile at 20 dpm in water was used as reference 
 
